Monday, June 29, 2026

North Korea Says 9th Party Congress Imminent… Tightens Control Over Officials By Mentoring Them On “Bone-Aching Hardship”

North Korea gears up for the 9th Party Congress, emphasizing officials' service to the people and nationwide mobilization for achievements.

North Korea Sends $2 Million in Scholarships to Japan-Based Pro-Pyongyang Group

Kim Jong Un donated $2 million to support education for Korean children in Japan, marking Kim Il Sung's birthday anniversary.

Unveiling 30 Years Later: South Korea and Israel’s Secret Defense Talks on North Korean Arms

Declassified documents reveal South Korea and Israel's 1990s efforts to form a joint task force addressing North Korea's arms exports.

Tag: Hanmi Pharmaceutical

A Record Year in China Is Giving Hanmi Pharmaceutical More Firepower for What’s Next

Hanmi Pharmaceutical's Chinese subsidiary surpassed $290M in sales, contributing significantly to the group's growth and future investments.

Hanmi Pharmaceutical’s Leadership Shake-Up: What Does New CEO Hwang Sang-yeon Mean for the Future?

Hanmi Pharmaceutical Group's management dispute appears to be resolved, marking its first external leadership in 53 years.

Hanmi Posts Record $1.16B Sales and $193M Operating Profit: What’s Driving the 2025 Surge

Hanmi Pharmaceutical reports record sales of $1.16 billion in January 2025, with significant growth in profits and new product launches.

FDA Grants Breakthrough Therapy Designation to Hanmi’s Epheglucagon: What This Means for Rare Disease Treatment

Hanmi Pharmaceutical's efpegerglucagon receives FDA Breakthrough Therapy designation for treating rare Congenital Hyperinsulinism, with Phase 2 results due soon.

How MiniRin and Nokdernah Are Revolutionizing Nocturia Care for Seniors: A Comprehensive Guide

Hanmi Pharmaceutical and Ferring Korea partner to distribute Minirin and Nocdurna for nocturia treatment, enhancing patient access.

Top News

- Our Sponsors Ad -

Follow us